| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Executive Officer
2 companies
Gregory Scott Duncan is Director at CRMD, with reported holdings spanning 2 companies. Gregory Scott Duncan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $442K at current prices.
Our model assigns Gregory Scott Duncan a below-average insider score of 32/100, based on 5 past trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -60.4%.
Gregory Scott Duncan's largest disclosed position is in CRMD as Director, worth about $382K.
Gregory Scott Duncan has 23 Form 4 filings on record from November 2020 to March 2026, across 2 companies: Chief Executive Officer at Dogwood Therapeutics (DWTX), 2020–2026; Director at CorMedix (CRMD), 2020–2026.
The 24 reported transactions were 15 option or other derivative awards, 5 open-market purchases, 2 stock awards and 2 option exercises.
Counted by filing, the open-market trades come to 5 purchases worth about $192K and no sales.
The largest open-market purchase was 15,675 shares of DWTX at an average $6.17 on April 5, 2021, about $97K. Twelve months later DWTX was down 26%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 25,000 | $1.25 | $31,245.00 | +77.0% | -38.8% | -84.2% | |
| May 23, 2022 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 7,500 | $4.52 | $33,900.00 | +30.0% | +45.5% | -72.3% | |
| Dec 21, 2021 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 5,000 | $5.52 | $27,615.00 | +25.0% | -2.1% | -95.8% | |
| Apr 6, 2021 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 382 | $6.36 | $2,428.60 | +2.0% | +5.0% | -24.4% | |
| Apr 5, 2021 | DWTX Dogwood Therapeutics, Inc. | Chief Executive Officer | Buy | 15,675 | $6.17 | $96,757.07 | +401.5% | +1.0% | -25.5% |